Screener
Ironwood Pharmaceuticals IRWD Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $113.04M+32.6% | $106.51M+159% | $47.71M-47.3% | $122.06M+33.3% | $85.24M-9.7% | ||
| $22.42M-4.1% | $21.94M-20.0% | $21.86M-13.9% | $22.47M-24.7% | $23.37M-23.1% | ||
| $11.31M-32.6% | $12.03M-50.4% | $19.29M-42.6% | $21.91M-39.3% | $16.8M-54.6% | ||
| $33.73M-15.5% | $33.93M-51.7% | $40.9M-30.7% | $46.58M-29.4% | $39.92M-42.5% | ||
| $79.31M+75.0% | $72.57M+349% | $6.81M-78.4% | $75.48M+194% | $45.32M+81.5% | ||
| 70.2%+17.0pp | 68.1%+139pp | 14.3%-20.5pp | 61.8%+33.9pp | 53.2%+26.7pp | ||
| $7.2M-13.8% | $9.14M+13.3% | $7.89M-11.5% | $8.43M-10.5% | $8.36M+11.9% | ||
| -$5.58M+25.6% | -$7.4M-3.3% | -$6.35M+15.3% | -$7.46M+9.7% | -$7.5M-22.9% | ||
| $73.73M+94.9% | $65.17M+280% | $455K-98.1% | $68.02M+292% | $37.82M+100% | ||
| $22.44M+57.8% | $24.4M+2,090% | $2.73M-87.4% | $27.94M+104% | $14.22M-27.9% | ||
| $51.29M+117% | $40.77M+209% | -$2.28M-201% | $40.08M+999% | $23.6M+2,844% | ||
| 45.4%+17.7pp | 38.3%+129pp | -4.8%-7.3pp | 32.8%+28.9pp | 27.7%+28.6pp | ||
| $0.31+121% | $0.24+204% | -$0.01-200% | $0.23+1,050% | $0.14+1,500% | ||
| $79.76M+74.2% | $73.02M+355% | $7.27M-77.1% | $75.96M+193% | $45.79M+81.1% | ||
| 70.6%+16.8pp | 68.6%+138pp | 15.2%-19.9pp | 62.2%+33.9pp | 53.7%+26.9pp | ||
| $79.31M+75.0% | $72.57M+349% | $6.81M-78.4% | $75.48M+194% | $45.32M+81.5% |
FAQ
- What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals (IRWD) generated $389.3M in revenue over the trailing twelve months, up 26.2% year over year.
- Is Ironwood Pharmaceuticals profitable?
- Ironwood Pharmaceuticals reported $129.9M in net income over the trailing twelve months, a 33.4% net margin.
- What are Ironwood Pharmaceuticals's profit margins?
- Gross margin is 99.2% and operating margin is 60.1%, with a 33.4% net margin.
- What is Ironwood Pharmaceuticals's earnings per share?
- Ironwood Pharmaceuticals's diluted EPS over the trailing twelve months is $0.77.
- Where does Ironwood Pharmaceuticals's income statement data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
